Mode
Text Size
Log in / Sign up
N/A Completed N=40

Intraoperative Case Series Study: Trial Rasp Position Versus SL-PLUS™ MIA Ti/HA Femoral Hip Stem Position

Source: ClinicalTrials.gov NCT02664272 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcomePrimary: Mean Difference D Between the Position of the Last Trial Rasp and the Final Implant Position of the SL-PLUS™ MIA Ti/HA Femoral Hip Stem as Measured by an Intraoperative Fluoroscopic Measurement — 7.78; 5.15; 2.63 mm

Summary

A prospective, multicenter, observational study using the SL-PLUS™ MIA Ti/HA femoral hip stem with the appropriate set of instruments.

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Difference D Between the Position of the Last Trial Rasp and the Final Implant Position of the SL-PLUS™ MIA Ti/HA Femoral Hip Stem as Measured by an Intraoperative Fluoroscopic Measurement
7.78; 5.15; 2.63 —
SECONDARY
Number of Hips With Leg Length Discrepancy
24; 1; 16; 36; 1; 4 —
SECONDARY
Number of Hips With Intraoperative Complications
0; 0 —

Eligibility Criteria

Inclusion Criteria

Patient:

  • requires primary THA with the SL-PLUS™ MIA Ti/HA femoral hip stem
  • is at least 21 years of age at the time of surgery
  • is skeletally mature in the PI's judgment
  • has consented to participate in the study by signing the EC approved ICF

Exclusion Criteria

Patient:

  • requires the use of a ceramic-on-ceramic bearing
  • has infections, acute or chronic, local or systemic
  • has severe muscle, nerve or vascular diseases that endanger the respective limb
  • has lack of bone substance or defective bone quality that jeopardizes the stable seating of the prosthesis
  • has any concomitant disease that may jeopardize implant function
  • has a known allergy to study device or one or more of its components
  • requires a revision surgery and has extensive bone defects
  • has diagnosis of an immunosuppressive disorder
  • is pregnant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02664272). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search